Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2022

Open Access 01-12-2022 | Hepatitis B | Case report

Recurrent hepatocellular carcinoma with osteoclast-like giant cells: a case report

Authors: Mone Tsukimoto, Kazushi Sugimoto, Ryuta Shigefuku, Ryosuke Sugimoto, Hiroto Yuasa, Katsunori Uchida, Norihiko Yamamoto

Published in: Journal of Medical Case Reports | Issue 1/2022

Login to get access

Abstract

Background

Hepatocellular carcinoma with osteoclast-like giant cells is very rare and has an extremely poor prognosis. Here, we report a case of hepatocellular carcinoma with osteoclast-like giant cells that had a relatively better prognosis.

Case presentation

A 70-year-old Japanese man with hepatitis B virus-related liver cirrhosis was admitted to our hospital for the treatment of recurrent hepatocellular carcinoma. At the age of 60 years, he was first diagnosed as having hepatocellular carcinoma in the right lobe (9 cm in diameter), and liver resection of segment 7/8 was performed. Histological findings showed well-differentiated hepatocellular carcinoma. Since then, imaging studies have been performed every 3 or 4 months. One year later, hepatocellular carcinoma recurred in the lateral segment, and radiofrequency ablation was performed. Nine years after the first presentation, hepatocellular carcinoma recurrences were detected in the caudate lobe and segment 5 by imaging studies. Surgical resection of the caudate lobe was performed, and ultrasonography-guided radiofrequency ablation was subsequently performed for the segment 5 tumor. The resected tumor was simple nodular, well-differentiated HCC; it measured 21 × 21 mm and contained many osteoclast-like giant cells. As neither vascular nor bile duct invasion was found, we believe that radical resection was achieved. Since then, the hepatocellular carcinoma has not recurred for over a year and a half.

Conclusion

Hepatocellular carcinoma with osteoclast-like giant cells is very rare and the prognosis is extremely poor, but early detection can lead to a better clinical course.
Literature
1.
go back to reference Kuwano H, Sonoda T, Hashimoto H, et al. Hepatocellular carcinoma with osteoclast-like giant cells. Cancer. 1984;54:837–42.CrossRef Kuwano H, Sonoda T, Hashimoto H, et al. Hepatocellular carcinoma with osteoclast-like giant cells. Cancer. 1984;54:837–42.CrossRef
2.
go back to reference Hood DL, Bauer TW, Leibel SA, et al. Hepatic giant cell carcinoma. An ultrastructural and immunohistochemical study. Am J Clin Pathol. 1990;93:111–6.CrossRef Hood DL, Bauer TW, Leibel SA, et al. Hepatic giant cell carcinoma. An ultrastructural and immunohistochemical study. Am J Clin Pathol. 1990;93:111–6.CrossRef
3.
go back to reference McCluggage WG, Toner PG. Hepatocellular carcinoma with osteoclast-like giant cells. Histopathology. 1993;23:187–9.CrossRef McCluggage WG, Toner PG. Hepatocellular carcinoma with osteoclast-like giant cells. Histopathology. 1993;23:187–9.CrossRef
4.
go back to reference Sasaki A, Yokoyama S, Nakayama I, et al. Sarcomatoid hepatocellular carcinoma with osteoclast-like giant cells: case report and immunohistochemical observations. Pathol Int. 1997;47:318–24.CrossRef Sasaki A, Yokoyama S, Nakayama I, et al. Sarcomatoid hepatocellular carcinoma with osteoclast-like giant cells: case report and immunohistochemical observations. Pathol Int. 1997;47:318–24.CrossRef
5.
go back to reference Ikeda T, Seki S, Maki M, et al. Hepatocellular carcinoma with osteoclast-like giant cells: possibility of osteoclastogenesis by hepatocyte-derived cells. Pathol Int. 2003;53:450–6.CrossRef Ikeda T, Seki S, Maki M, et al. Hepatocellular carcinoma with osteoclast-like giant cells: possibility of osteoclastogenesis by hepatocyte-derived cells. Pathol Int. 2003;53:450–6.CrossRef
6.
go back to reference Rudloff U, Gao ZQ, Fields S, et al. Osteoclast-like giant cell tumor of the liver: a rare neoplasm with an aggressive clinical course. J Gastrointest Surg. 2005;9:207–14.CrossRef Rudloff U, Gao ZQ, Fields S, et al. Osteoclast-like giant cell tumor of the liver: a rare neoplasm with an aggressive clinical course. J Gastrointest Surg. 2005;9:207–14.CrossRef
7.
go back to reference Tanahashi C, Nagae H, Nukaya T, et al. Combined hepatocellular carcinoma and osteoclast-like giant cell tumor of the liver: possible clue to histogenesis. Pathol Int. 2009;59:813–6.CrossRef Tanahashi C, Nagae H, Nukaya T, et al. Combined hepatocellular carcinoma and osteoclast-like giant cell tumor of the liver: possible clue to histogenesis. Pathol Int. 2009;59:813–6.CrossRef
8.
go back to reference Lee KB. Sarcomatoid hepatocellular carcinoma with mixed osteoclast-like giant cells and chondroid differentiation. Clin Mol Hepatol. 2014;20:313–6.CrossRef Lee KB. Sarcomatoid hepatocellular carcinoma with mixed osteoclast-like giant cells and chondroid differentiation. Clin Mol Hepatol. 2014;20:313–6.CrossRef
10.
go back to reference Kim HM, Kim H, Park YN. Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: a case report. Clin Mol Hepatol. 2015;21:309–13.CrossRef Kim HM, Kim H, Park YN. Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: a case report. Clin Mol Hepatol. 2015;21:309–13.CrossRef
11.
go back to reference Tetsuya H, Fumitaka S, Masahiro K, et al. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology. 2013;58(1):98–107. Tetsuya H, Fumitaka S, Masahiro K, et al. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology. 2013;58(1):98–107.
12.
go back to reference Tetsuya H, Fumitaka S, Masahiro K, et al. Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues. Aliment Pharmacol Ther. 2019;49:457–71.CrossRef Tetsuya H, Fumitaka S, Masahiro K, et al. Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues. Aliment Pharmacol Ther. 2019;49:457–71.CrossRef
Metadata
Title
Recurrent hepatocellular carcinoma with osteoclast-like giant cells: a case report
Authors
Mone Tsukimoto
Kazushi Sugimoto
Ryuta Shigefuku
Ryosuke Sugimoto
Hiroto Yuasa
Katsunori Uchida
Norihiko Yamamoto
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2022
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-022-03355-1

Other articles of this Issue 1/2022

Journal of Medical Case Reports 1/2022 Go to the issue